Kremer J, Bingham C, Cappelli L, et al. Post-appoval comparative safety study of tofacitinib and biological DMARDS: five-year results from a US-based rheumatoid arthritis registry. EULAR 2019; Madrid: Abstract OP0028.
Fracturen en opioïden, SSRI’s en glucocorticoïden
jun 2019 | Osteoporose, RA